A gentle touch may soothe Preemies' pain during blood tests

NCT ID NCT07715682

Recruiting now Symptom relief Sponsor: Kubra Nur Kabakcı Sarıdağ Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether gentle human touch and reducing light and sound (using an eye mask and earplug) can lessen pain and improve comfort for premature infants during a routine heel prick blood test. Sixty preterm babies (32–36 weeks gestation) are randomly assigned to receive gentle touch, stimulus reduction, or standard care with a pacifier. Pain and comfort are measured before, during, and after the procedure to see if these simple, drug-free approaches help.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: gentle human touch and stimulus reduction (eye mask and earplug)
What this could lead to: If effective, these simple, non-drug methods could become standard practice to reduce pain and stress in premature infants during routine procedures.
What could go wrong: This is a small, early-stage trial with 60 infants, so results may not apply broadly. The interventions may not significantly reduce pain compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL INTENSIVE CARE UNIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEONATAL INTENSIVE CARE UNIT NURSING CARE PREMATURE TOUCH

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Etlik City Hospital
RECRUITING

Ankara, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.